{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:47:55Z","timestamp":1787892475987,"version":"build-2784847793"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Carcinoid heart disease (CHD), a complication of carcinoid syndrome (CS), is a rare condition that can lead to right sided valvular heart disease and has been traditionally associated with a poor prognosis. We conducted a systematic review and meta-analysis to explore the accuracy of biomarkers and echocardiography in diagnosing CHD amongst patients who are already known to have neuroendocrine tumours and to assess whether surgical management of CHD leads to a reduction in mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic literature search of MEDLINE, EMBASE, EBM Reviews, Google Scholar, ClinicalTrials.gov was conducted. All studies on patients with carcinoid heart disease (CHD) reporting on biomarkers, echocardiographic and surgical outcomes were included. The National Heart, Lung, and Blood Institute quality assessment tool was used to assess the methodological study quality. Data analysis was performed using Stata Statistical Software and R Studio, and individual meta-analyses were performed for biomarkers, echocardiographic findings, and surgical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 36 articles were included in the systematic review analysis. N terminal pro-brain natriuretic peptide (NTproBNP) and 5-hydroxyindole acetate (5-HIAA) levels were higher in patients with CHD compared with those without CHD. 32% of CS patients had echocardiographic evidence of cardiac involvement, of which 79% involved tricuspid valve abnormalities. Moderate-severe tricuspid regurgitation was the most common echocardiographic abnormality (70% of patients). However, these analyses had substantial heterogeneity due to the high variability of cardiac involvement across studies. Pooled surgical mortality for CHD was 11% at 1 month, 31% at 12 months and 56% at 24 months. When assessing surgical outcomes longitudinally, the one-month surgical results showed a trend towards more recent surgeries having lower mortality rates than those reported in earlier years, however this was not statistically significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>There is not enough data in current literature to determine a clear cut-off value of NTproBNP and 5-HIAA to help diagnose or determine CHD severity. Surgical management of CHD is yet to show significant mortality benefit, and there are no consistent comparisons to medical treatment in current literature.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1353612","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T05:16:14Z","timestamp":1710911774000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Jenny","family":"Namkoong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabha H.","family":"Andraweera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maleesa","family":"Pathirana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Munawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Downie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Averbuj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Arstall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ecl.2018.04.012","article-title":"Carcinoid heart disease: a review","volume":"47","author":"Hayes","year":"2018","journal-title":"Endocr Metab Clinics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/jcm8030405","article-title":"Carcinoid heart disease and decreased overall survival among patients with neuroendocrine tumors: a retrospective multicenter Latin American cohort study","volume":"8","author":"Uema","year":"2019","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3332\/ecancer.2018.879","article-title":"High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease","volume":"12","author":"Alves","year":"2018","journal-title":"ecancermedicalscience"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e13146","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine tumor society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease","volume":"34","author":"Grozinsky-Glasberg","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.athoracsur.2019.03.004","article-title":"Outcomes of isolated tricuspid valve surgery have improved in the modern era","volume":"108","author":"Hamandi","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1093\/eurheartj\/ehaa643","article-title":"Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes","volume":"41","author":"Dreyfus","year":"2020","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.amjcard.2008.05.047","article-title":"Usefulness of N-terminal pro\u2013brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease","volume":"102","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e73679","DOI":"10.1371\/journal.pone.0073679","article-title":"The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study","volume":"8","author":"Dobson","year":"2013","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2014.02.037","article-title":"The clinical presentation and management of carcinoid heart disease","volume":"173","author":"Dobson","year":"2014","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/bjc.2014.468","article-title":"Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality","volume":"111","author":"Dobson","year":"2014","journal-title":"Br J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/sj.bjc.6601816","article-title":"Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease","volume":"90","author":"Zuetenhorst","year":"2004","journal-title":"Br J Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0735-1097(98)00354-4","article-title":"Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease","volume":"32","author":"Denney","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.echo.2011.02.009","article-title":"Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease","volume":"24","author":"Haugaa","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0002-9149(89)90344-5","article-title":"Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease","volume":"63","author":"Himelman","year":"1989","journal-title":"Am J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s11748-010-0758-9","article-title":"Cardiac surgery for carcinoid heart disease in 12 cases","volume":"59","author":"Komoda","year":"2011","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.amjcard.2009.10.023","article-title":"Comparison of prognostic value of tissue doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease","volume":"105","author":"Mansencal","year":"2010","journal-title":"Am J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/ejcts\/ezr227","article-title":"Carcinoid heart disease: outcomes after surgical valve replacement","volume":"41","author":"Mokhles","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease: analysis of 200 cases over two decades","volume":"112","author":"M\u00f8ller","year":"2005","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2-and 3-dimensional echocardiography and cardiac MRI","volume":"3","author":"Bhattacharyya","year":"2010","journal-title":"Circ Cardiovas Imaging"},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/hrt.64.3.190","article-title":"Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease","volume":"64","author":"Lundin","year":"1990","journal-title":"Heart"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.amjcard.2010.01.017","article-title":"Echocardiographic follow-up of treated patients with carcinoid syndrome","volume":"105","author":"Mansencal","year":"2010","journal-title":"Am J Cardiol"},{"key":"B23","first-page":"625","article-title":"Incidence and evolution of carcinoid syndrome in the heart","volume":"6","author":"Moyssakis","year":"1997","journal-title":"J Heart Valve Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jtcvs.2018.09.025","article-title":"Improving outcome of valve replacement for carcinoid heart disease","volume":"158","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharyya","year":"2011","journal-title":"Am J Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jacc.2007.12.036","article-title":"Early and late results of valvular surgery for carcinoid heart disease","volume":"51","author":"Castillo","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.jacc.2015.09.014","article-title":"Early and late outcomes of surgical treatment in carcinoid heart disease","volume":"66","author":"Connolly","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B29","first-page":"363","article-title":"Results of contemporary valve surgery in patients with carcinoid heart disease","volume":"356","author":"Kuntze","year":"2016","journal-title":"J Heart Valve Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/00015385.2018.1478242","article-title":"The path to surgery in carcinoid heart disease: a retrospective study and a multidisciplinary proposal of a new algorithm","volume":"74","author":"Mortelmans","year":"2019","journal-title":"Acta Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0002-9149(99)80586-4","article-title":"Predictors of outcome of tricuspid valve replacement in carcinoid heart disease","volume":"75","author":"Robiolio","year":"1995","journal-title":"Am J Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jtcvs.2013.09.043","article-title":"When should a mechanical tricuspid valve replacement be considered?","volume":"148","author":"Said","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/24748706.2019.1706795","article-title":"Outcomes after tricuspid valve replacement for carcinoid heart disease: a multicenter study","volume":"4","author":"Veen","year":"2020","journal-title":"Structural Heart"},{"key":"B35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.hlc.2019.05.183","article-title":"Early outcomes of surgery for carcinoid heart disease","volume":"29","author":"Yong","year":"2020","journal-title":"Heart Lung Circ"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B37","article-title":"Part1: cochrane reviews. Part 2: general methods for cochrane reviews","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 51","author":"Deeks","year":"2011"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1353612\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T05:16:19Z","timestamp":1710911779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1353612\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2024.1353612"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1353612","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"article-number":"1353612"}}